Physician profile
Christopher P Larussa
NPI 1710977616
$3,964.26
in general payments reported to CMS, 2019-2025
23 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,828 · 2020: $63.19 · 2021: $120 · 2022: $61.25 · 2023: $559 · 2024: $203 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $2,700.33 | 2019 | |
| Abbvie INC. | $375.67 | 2020-2025 | |
| Boston Scientific Corporation | $183.23 | 2023-2024 | Solyx Sis System |
| Bayer Healthcare Pharmaceuticals INC. | $88.52 | 2019-2023 | |
| Allergan, INC. | $74.05 | 2019-2020 | |
| Organon LLC | $57.32 | 2023 | Nexplanon |
| Astellas Pharma US INC | $56.85 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $56.69 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $55.63 | 2019-2025 | Paragard T 380a |
| Novo Nordisk INC | $52.93 | 2023-2024 | Wegovy |
| Biogen, INC. | $42.23 | 2025 | Zurzuvae |
| Axonics, INC. | $29.94 | 2023 | Bulkamid |
| Mayne Pharma Commercial LLC | $28.85 | 2024 | |
| Agile Therapeutics, INC. | $23.66 | 2023 | Twirla |
| Exact Sciences Corporation | $18.30 | 2024 | Cologuard Collection Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.97 | 2024 | Zepbound |
| Hologic Sales and Service, LLC | $16.30 | 2023 | Myosure Tissue Removal Device, Coolseal Generator |
| Meditrina | $15.93 | 2021 | |
| Sage Therapeutics, LLC | $15.53 | 2019 | |
| Amgen INC. | $15.13 | 2023 | Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $14.41 | 2024 | Xarelto |
| Pfizer INC. | $12.96 | 2021 | |
| Lupin INC. | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Larussa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.